Falls and functional impairments in cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study
- PMID: 23446880
- PMCID: PMC3669650
- DOI: 10.1007/s00520-013-1766-y
Falls and functional impairments in cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study
Abstract
Purpose: This study was conducted in order to characterize the prevalence of falls and functional impairments (FIs) and their association with chemotherapy-induced peripheral neuropathy (CIPN) in cancer survivors.
Methods: We analyzed baseline assessments from a phase III RCT in cancer survivors with self-reported CIPN scores of >4 out of 10. Patients completed the EORTC QLQ-CIPN-20 for neuropathy and reported falls in the previous 3 months. FIs were defined using the Activities of Daily Living subsection of the Vulnerable Elder's Scale. Associations of baseline characteristics and CIPN with falls and FIs were examined using logistic regression.
Results: Of 421 patients, 11.9 % experienced recent falls and 26.6 % reported FIs. Motor neuropathy was the only factor associated with falls (OR = 1.127, p = 0.01). Factors associated with FIs included non-white race (OR = 0.335 white relative to non-white, 0.781, p = 0.01) and greater motor neuropathy scores (OR = 1.262, p < 0.0001).
Conclusion: CIPN, primarily motor, is associated with falls and FIs. Future prospective research should investigate the ability of motor neuropathy severity to predict falls.
Conflict of interest statement
Figures
Similar articles
-
Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk.Breast Cancer Res Treat. 2016 Sep;159(2):327-33. doi: 10.1007/s10549-016-3939-0. Epub 2016 Aug 10. Breast Cancer Res Treat. 2016. PMID: 27510185 Free PMC article.
-
Falls, Functioning, and Disability Among Women With Persistent Symptoms of Chemotherapy-Induced Peripheral Neuropathy.J Clin Oncol. 2017 Aug 10;35(23):2604-2612. doi: 10.1200/JCO.2016.71.3552. Epub 2017 Jun 6. J Clin Oncol. 2017. PMID: 28586243 Free PMC article.
-
Falls and Functional Impairments in Breast Cancer Patients with Chemotherapy-Induced Peripheral Neuropathy.Asia Pac J Oncol Nurs. 2019 Jul-Sep;6(3):253-260. doi: 10.4103/apjon.apjon_7_19. Asia Pac J Oncol Nurs. 2019. PMID: 31259221 Free PMC article.
-
Chemotherapy-Induced Peripheral Neuropathy: Association With Increased Risk of Falls and Injuries.Clin J Oncol Nurs. 2019 Aug 1;23(4):405-410. doi: 10.1188/19.CJON.405-410. Clin J Oncol Nurs. 2019. PMID: 31322611 Review.
-
Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline.J Clin Oncol. 2014 Jun 20;32(18):1941-67. doi: 10.1200/JCO.2013.54.0914. Epub 2014 Apr 14. J Clin Oncol. 2014. PMID: 24733808 Review.
Cited by
-
Chronic Distal Sensory Polyneuropathy Is a Major Contributor to Balance Disturbances in Persons Living With HIV.J Acquir Immune Defic Syndr. 2019 Apr 15;80(5):568-573. doi: 10.1097/QAI.0000000000001953. J Acquir Immune Defic Syndr. 2019. PMID: 30649035 Free PMC article.
-
Fall predictors in hospitalized patients living with cancer: a case-control study.Support Care Cancer. 2022 Oct;30(10):7835-7843. doi: 10.1007/s00520-022-07208-x. Epub 2022 Jun 16. Support Care Cancer. 2022. PMID: 35705752
-
Factors associated with falls in older adults with cancer: a validated model from the Cancer and Aging Research Group.Support Care Cancer. 2018 Oct;26(10):3563-3570. doi: 10.1007/s00520-018-4212-3. Epub 2018 Apr 28. Support Care Cancer. 2018. PMID: 29705872 Free PMC article.
-
Development of the consensus-based recommendations for Podiatry care of Neuropathy In Cancer Survivors (PodNICS): a Delphi consensus study of Australian podiatrists.J Foot Ankle Res. 2023 Jun 9;16(1):33. doi: 10.1186/s13047-023-00632-0. J Foot Ankle Res. 2023. PMID: 37291602 Free PMC article.
-
Dietary quality and chemotherapy-induced peripheral neuropathy in colon cancer.Cancer. 2025 Jan 1;131(1):e35599. doi: 10.1002/cncr.35599. Epub 2024 Oct 5. Cancer. 2025. PMID: 39369275 Clinical Trial.
References
-
- Ocean AJ, Vahdat LT. Chemotherapy-induced peripheral neuropathy: pathogenesis and emerging therapies. Support Care Cancer. 2004;12(9):619–625. - PubMed
-
- Argyriou AA, Koltzenburg M, Polychronopoulos P, Papapetropoulos S, Kalofonos HP. Peripheral nerve damage associated with administration of taxanes in patients with cancer. Crit Rev Oncol Hematol. 2008;66(3):218–228. - PubMed
-
- Dougherty PM, Cata JP, Cordella JV, Burton A, Weng HR. Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients. Pain. 2004;109(1–2):132–142. - PubMed
-
- Quasthoff S, Hartung HP. Chemotherapy-induced peripheral neuropathy. J Neurol. 2002;249(1):9–17. - PubMed
-
- Windebank AJ, Grisold W. Chemotherapy-induced neuropathy. J Peripher Nerv Syst. 2008;13(1):27–46. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical